Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
In terms of fertility and triple negative breast cancer, in patients with early stage triple negative breast cancer, the treatment for many includes chemotherapy that can affect fertility in the future. So it is always important to consider fertility preservation therapies. We have several studies that, A, it's effective and safe to do fertility preservation treatment before treatment for breast cancer, and B, that we will usually ask patients to wait a year or two after the treatment of breast cancer, but that pregnancy is safe and feasible. So making sure to discuss with the patient about this before giving any chemotherapy because we can impact their reproductive health in the future.
In this video, Ilana Schlam, MD, MPH, discusses the importance of speaking with patients about fertility preservation therapies before initiating treatment for triple-negative breast cancer.
Schlam, breast medical oncologist at Dana-Farber Cancer Institute, emphasized having these conversations “before giving any chemotherapy, because we can impact their reproductive health in the future.”
